Methods involving long lasting synthetic exendin-4 peptide conjugates
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 10, 2012
Grant Date -
Jun 22, 2006
app pub date -
Dec 14, 2005
filing date -
May 17, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Modified insulinotropic peptides are disclosed. The modified insulinotropic peptides are capable of forming a peptidase stabilized insulinotropic peptide. The modified insulinotropic peptides are capable of forming covalent bonds with one or more blood components to form a conjugate. The conjugates may be formed in vivo or ex vivo. The modified peptides are administered to treat humans with diabetes and other related diseases.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully